Heron Therapeutics to report Q3 2026 financial results on Nov 9 with live webcast.

Heron Therapeutics, a biotechnology company, announced it will release its third quarter 2026 financial results on Monday, November 9, 2026. The company will host a conference call and live webcast at 8:30 a.m. ET to discuss the results and recent business highlights. Investors can access the call via phone or webcast through Heron's website, with an archive available for 60 days. This update is important for investors tracking Heron's progress in developing and commercializing innovative therapies for acute care and oncology patients.

Heron Therapeutics shares are trading at USD 0.30 on Pluang as of October 27, 2026, 07:11 WIB. The stock has a market cap of $57.49 million and has seen a slight 0.33% decrease in the last day. Investor interest remains strong with 78% of recent orders being buys, reflecting ongoing attention ahead of the upcoming earnings release.